Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Alzheimer's Disease

  Free Subscription


12.07.2021

1 Alzheimers Dement
1 Am J Geriatr Psychiatry
2 Biochemistry (Mosc)
1 BMC Neurol
1 BMJ
2 Curr Alzheimer Res
1 Curr Opin Neurol
10 J Alzheimers Dis
1 J Biol Chem
1 J Neurochem
1 Lancet
1 Lancet Neurol
1 Nat Med
1 Nat Rev Neurol
1 Neurobiol Aging
1 Neurologia (Engl Ed)
1 Neurology
1 Neuropsychology
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Alzheimers Dement

  1. BOCHE D, Gordon MN
    Diversity of transcriptomic microglial phenotypes in aging and Alzheimer's disease.
    Alzheimers Dement. 2021 Jul 5. doi: 10.1002/alz.12389.
    PubMed         Abstract available


    Am J Geriatr Psychiatry

  2. KRELL-ROESCH J, Syrjanen JA, Vassilaki M, Lowe VJ, et al
    Brain Regional Glucose Metabolism, Neuropsychiatric Symptoms, and the Risk of Incident Mild Cognitive Impairment: The Mayo Clinic Study of Aging.
    Am J Geriatr Psychiatry. 2021;29:179-191.
    PubMed         Abstract available


    Biochemistry (Mosc)

  3. BABUSIKOVA E, Dobrota D, Turner AJ, Nalivaeva NN, et al
    Effect of Global Brain Ischemia on Amyloid Precursor Protein Metabolism and Expression of Amyloid-Degrading Enzymes in Rat Cortex: Role in Pathogenesis of Alzheimer's Disease.
    Biochemistry (Mosc). 2021;86:680-692.
    PubMed         Abstract available

  4. SUKHORUKOV VS, Mudzhiri NM, Voronkova AS, Baranich TI, et al
    Mitochondrial Disorders in Alzheimer's Disease.
    Biochemistry (Mosc). 2021;86:667-679.
    PubMed         Abstract available


    BMC Neurol

  5. WANG L, Li P, Hou M, Zhang X, et al
    Construction of a risk prediction model for Alzheimer's disease in the elderly population.
    BMC Neurol. 2021;21:271.
    PubMed         Abstract available


    BMJ

  6. WALSH S, Merrick R, Milne R, Brayne C, et al
    Aducanumab for Alzheimer's disease?
    BMJ. 2021;374:n1682.
    PubMed        


    Curr Alzheimer Res

  7. LAZZARI C, Kotera Y, Green P, Rabottini M, et al
    Social Network Analysis of Alzheimer's Teams: A Clinical Review and Applications in Psychiatry to Explore Interprofessional Care.
    Curr Alzheimer Res. 2021 Jul 1. pii: CAR-EPUB-116419.
    PubMed         Abstract available

  8. CHO SH, Rhee HY, Oh J, Lee JS, et al
    Longitudinal Functional Magnetic Resonance Spectroscopy Study in Subjects with Mild Cognitive Impairment and Alzheimer's Disease.
    Curr Alzheimer Res. 2021 Jul 8. pii: CAR-EPUB-116583.
    PubMed         Abstract available


    Curr Opin Neurol

  9. SCAMARCIA PG, Agosta F, Caso F, Filippi M, et al
    Update on neuroimaging in non-Alzheimer's disease dementia: a focus on the Lewy body disease spectrum.
    Curr Opin Neurol. 2021;34:532-538.
    PubMed         Abstract available


    J Alzheimers Dis

  10. GABRIEL A, Lehner CT, Hohler C, Schneider T, et al
    Anticipatory and Reactive Grip Force Control in Patients with Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2021 Jun 30. pii: JAD210387. doi: 10.3233/JAD-210387.
    PubMed         Abstract available

  11. BEARDMORE R, Hou R, Darekar A, Holmes C, et al
    The Locus Coeruleus in Aging and Alzheimer's Disease: A Postmortem and Brain Imaging Review.
    J Alzheimers Dis. 2021 Jul 2. pii: JAD210191. doi: 10.3233/JAD-210191.
    PubMed         Abstract available

  12. FRANK M, Hensel J, Baak L, Schramm S, et al
    Interaction of Alzheimer's Disease-Associated Genetic Risk with Indicators of Socioeconomic Position on Mild Cognitive Impairment in the Heinz Nixdorf Recall Study.
    J Alzheimers Dis. 2021 Jun 28. pii: JAD210244. doi: 10.3233/JAD-210244.
    PubMed         Abstract available

  13. JOSEPH S, Patterson R, Wang W, Blumberger DM, et al
    Quantitative Assessment of Cortical Excitability in Alzheimer's Dementia and Its Association with Clinical Symptoms: A Systematic Review and Meta-Analyses.
    J Alzheimers Dis. 2021 Jul 2. pii: JAD210311. doi: 10.3233/JAD-210311.
    PubMed         Abstract available

  14. MANCINI G, Dias C, Lourenco CF, Laranjinha J, et al
    A High Fat/Cholesterol Diet Recapitulates Some Alzheimer's Disease-Like Features in Mice: Focus on Hippocampal Mitochondrial Dysfunction.
    J Alzheimers Dis. 2021 Jun 28. pii: JAD210122. doi: 10.3233/JAD-210122.
    PubMed         Abstract available

  15. KUWAR R, Rolfe A, Di L, Blevins H, et al
    A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer's Disease Transgenic Mice.
    J Alzheimers Dis. 2021 Jul 1. pii: JAD210400. doi: 10.3233/JAD-210400.
    PubMed         Abstract available

  16. HOJJATI SH, Feiz F, Ozoria S, Razlighi QR, et al
    Topographical Overlapping of the Amyloid-beta and Tau Pathologies in the Default Mode Network Predicts Alzheimer's Disease with Higher Specificity.
    J Alzheimers Dis. 2021 Jul 1. pii: JAD210419. doi: 10.3233/JAD-210419.
    PubMed         Abstract available

  17. DAVOUDI A, Dion C, Amini S, Tighe PJ, et al
    Classifying Non-Dementia and Alzheimer's Disease/Vascular Dementia Patients Using Kinematic, Time-Based, and Visuospatial Parameters: The Digital Clock Drawing Test.
    J Alzheimers Dis. 2021;82:47-57.
    PubMed         Abstract available

  18. SQUITTI R, Faller P, Hureau C, Granzotto A, et al
    Copper Imbalance in Alzheimer's Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology.
    J Alzheimers Dis. 2021 Jul 2. pii: JAD201556. doi: 10.3233/JAD-201556.
    PubMed         Abstract available

  19. BAENA A, Bocanegra Y, Torres V, Vila-Castelar C, et al
    Neuroticism Is Associated with Tau Pathology in Cognitively Unimpaired Individuals with Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 30. pii: JAD210185. doi: 10.3233/JAD-210185.
    PubMed         Abstract available


    J Biol Chem

  20. KAYED R
    Infectious Etiology and Amyloidosis in Alzheimer's Disease: The Puzzle Continues.
    J Biol Chem. 2021 Jul 1:100936. doi: 10.1016/j.jbc.2021.100936.
    PubMed         Abstract available


    J Neurochem


  21. Retraction: Clinical trials in Alzheimer's disease': immunotherapy approaches.
    J Neurochem. 2021 Jul 6. doi: 10.1111/jnc.15435.
    PubMed         Abstract available


    Lancet

  22. JAFFE S
    US FDA defends approval of Alzheimer's disease drug.
    Lancet. 2021;398:12.
    PubMed        


    Lancet Neurol

  23. THE LANCET NEUROLOGY
    A contentious FDA ruling for Alzheimer's disease.
    Lancet Neurol. 2021 Jul 5. pii: S1474-4422(21)00215.
    PubMed        


    Nat Med

  24. RABINOVICI GD
    Dominantly inherited Alzheimer's disease: a compass for drug development.
    Nat Med. 2021 Jul 5. pii: 10.1038/s41591-021-01434.
    PubMed        


    Nat Rev Neurol

  25. HAMPEL H, Cummings J, Blennow K, Gao P, et al
    Developing the ATX(N) classification for use across the Alzheimer disease continuum.
    Nat Rev Neurol. 2021 Jul 8. pii: 10.1038/s41582-021-00520.
    PubMed         Abstract available


    Neurobiol Aging

  26. JUNG JH, Jeon S, Baik K, Lee YH, et al
    Apolipoprotein E4, amyloid, and cognition in Alzheimer's and Lewy body disease.
    Neurobiol Aging. 2021;106:45-54.
    PubMed         Abstract available


    Neurologia (Engl Ed)

  27. JORGE C, Ceto M, Arias A, Blasco E, et al
    Level of understanding of Alzheimer disease among caregivers and the general population.
    Neurologia (Engl Ed). 2021;36:426-432.
    PubMed         Abstract available


    Neurology

  28. SALLOWAY S, Cummings J
    Aducanumab, Amyloid Lowering, and Slowing of Alzheimer Disease.
    Neurology. 2021 Jul 7. pii: WNL.0000000000012451.
    PubMed        


    Neuropsychology

  29. CHANG M, Brainerd CJ
    Factor analyses of the ADNI neuropsychological battery: An examination of diagnostic and longitudinal invariance.
    Neuropsychology. 2021;35:434-450.
    PubMed         Abstract available


    PLoS One

  30. RHEW SH, Kravchenko J, Lyerly HK
    Exposure to low-dose ambient fine particulate matter PM2.5 and Alzheimer's disease, non-Alzheimer's dementia, and Parkinson's disease in North Carolina.
    PLoS One. 2021;16:e0253253.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: